PMID: 3012486Mar 1, 1986Paper

Acebutolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects

B N SinghJ Wahl


Acebutolol is a new hydrophilic, cardioselective beta-adrenergic-blocking agent that possesses partial agonist and membrane-stabilizing activities. In the treatment of mild to moderate essential hypertension, once-daily acebutolol as monotherapy provides effective control in a large majority of patients and produces a further reduction in blood pressure when used concomitantly with diuretics. Acebutolol is as effective as other beta-blocking agents, and in a large, double-blind, parallel study against propranolol was found to cause less reduction in heart rate, and fewer neurologic side effects and patient withdrawals due to adverse effects. Oral acebutolol is also effective in suppressing premature ventricular contractions, and in small numbers of patients generally beneficial results were obtained in supraventricular and ventricular arrhythmias with intravenous administration. These salutary effects are attributable to beta blockade. Controlled clinical trials documented the antianginal actions of oral acebutolol in chronic stable angina pectoris; its efficacy in this regard is comparable to that of other beta-blocking agents. The drug produces smaller decreases in heart rate and cardiac output and alterations in peripheral v...Continue Reading


Mar 1, 1976·Clinical Pharmacology and Therapeutics·P Biron, G Tremblay
May 1, 1976·The Journal of Pharmacy and Pharmacology·C M Kaye
Feb 1, 1976·British Journal of Clinical Pharmacology·C M Kaye, A D Long
Dec 1, 1977·The Journal of Pharmacy and Pharmacology·M D Day
Feb 1, 1978·British Heart Journal·P B DecalmerG M Sterling
May 1, 1978·British Journal of Clinical Pharmacology·M K BensonG S Sterling
Aug 1, 1979·Clinical Pharmacology and Therapeutics·R E VestalD G Shand
Jun 1, 1979·British Journal of Clinical Pharmacology·H R GribbinA E Tattersfield
Jun 1, 1979·British Journal of Clinical Pharmacology·R D Watson, W A Littler
May 21, 1979·European Journal of Clinical Pharmacology·T L SvendsenJ Trap-Jensen
Sep 1, 1979·The Journal of Pharmacy and Pharmacology·C F George, B S Gruchy
Oct 1, 1979·British Journal of Clinical Pharmacology·J F GiudicelliC Richer
Jul 19, 1975·Lancet·C R KumanaJ Hamer
May 1, 1977·Circulation·A H GradmanD C Harrison
Nov 4, 1978·Lancet·J D WilsonR J Booth
Mar 10, 1979·Lancet·B O Kristensen
Jun 1, 1979·Clinical Pharmacology and Therapeutics·R J CodyE L Bravo
Nov 1, 1977·Biochemical Pharmacology·N S DhallaM S Chauhan
Sep 1, 1975·The Journal of Clinical Investigation·J J LertoraF M Abboud
Oct 14, 1977·European Journal of Clinical Pharmacology·L HanssonM Holm
Jan 1, 1978·British Heart Journal·J W MasonE L Alderman
Jan 1, 1978·British Heart Journal·J W MasonD C Harrison
Jan 1, 1978·The Journal of International Medical Research·K Charoenlarp, N Jaroonvesama
Jun 1, 1978·British Heart Journal·P RizzonL Sorgente
Feb 1, 1979·Clinical Pharmacology and Therapeutics·W S AronowM Lurie
Sep 1, 1979·The American Journal of Cardiology·D O WilliamsA S Most
Jun 1, 1979·Circulation·S NattelG Van Loon
Jun 1, 1979·Clinical Pharmacology and Therapeutics·G L WollamE L Bravo
Jul 1, 1979·Clinical Pharmacology and Therapeutics·R E VestalG R Wilkinson
Jan 1, 1979·The Journal of International Medical Research·P G Baker, J Goulton
Nov 1, 1979·American Heart Journal·J L RodB S Lewis
Dec 16, 1977·European Journal of Clinical Pharmacology·K Kayed, O B Godtlibsen

❮ Previous
Next ❯


Jun 8, 2002·Pharmacogenomics·Peter Meisel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.